BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16467976)

  • 1. Osteoblast dysfunction in male idiopathic osteoporosis.
    Pernow Y; Granberg B; Sääf M; Weidenhielm L
    Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced proliferation and osteocalcin expression in osteoblasts of male idiopathic osteoporosis.
    Ruiz-Gaspà S; Blanch-Rubió J; Ciria-Recasens M; Monfort J; Tío L; Garcia-Giralt N; Nogués X; Monllau JC; Carbonell-Abelló J; Pérez-Edo L
    Calcif Tissue Int; 2010 Mar; 86(3):220-6. PubMed ID: 20101397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production.
    Bouillon R
    Verh K Acad Geneeskd Belg; 1992; 54(4):365-91; discussion 391-2. PubMed ID: 1466160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation.
    Marie PJ; de Vernejoul MC; Connes D; Hott M
    J Clin Invest; 1991 Oct; 88(4):1167-72. PubMed ID: 1918371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
    Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
    Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local estradiol metabolism in osteoblast- and osteoclast-like cells.
    Jakob F; Siggelkow H; Homann D; Köhrle J; Adamski J; Schütze N
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):167-74. PubMed ID: 9365187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
    Lomri A; Marie PJ
    J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of mechanical stimulation on the proliferation and synthetic function of osteoblasts from osteoporotic rat].
    Li L; Deng L; Chen M; Wu W; Mao Y; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):341-6, 349. PubMed ID: 15250129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between amino acids and bone mineral density in men with idiopathic osteoporosis.
    Pernow Y; Thorén M; Sääf M; Fernholm R; Anderstam B; Hauge EM; Hall K
    Bone; 2010 Nov; 47(5):959-65. PubMed ID: 20813216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids.
    Pagel CN; Song SJ; Loh LH; Tudor EM; Murray-Rust TA; Pike RN; Mackie EJ
    Bone; 2009 May; 44(5):813-21. PubMed ID: 19442625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.
    Spreafico A; Frediani B; Capperucci C; Leonini A; Gambera D; Ferrata P; Rosini S; Di Stefano A; Galeazzi M; Marcolongo R
    J Cell Biochem; 2006 Jul; 98(4):1007-20. PubMed ID: 16795077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro human osteoblast and extracellular matrix changes after transforming growth factor beta 1 treatment.
    Stabellini G; Vertemati M; Locci P; Calvitti M; Minola E; Calastrini C; Pellati A; Carinci F; Marinucci L; Lilli C; Baroni T
    Pathology; 2005 Oct; 37(5):347-54. PubMed ID: 16194844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
    Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
    J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
    Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
    Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.